The patients with ALK-negative ALCL bearing 17p loss and/or PRDM1 inactivation had an inferior OS, compared to the patients bearing no 17p loss and PRDM1 inactivation [42]. This evidence concerns the gene ALK and anaplastic large cell lymphoma.